ArticleJournal of the Royal Society, Interface2013
Aminosilane functionalizations of mesoporous oxidized silicon for oligonucleotide synthesis and detection.
Article in Journal of the Royal Society, Interface, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 69 citations in OpenAlex.
- ZnO Tetrapods for Label-Free Optical Biosensing: Physicochemical Characterization and Functionalization Strategies.International journal of molecular sciences · 2023Article
- Article
- An Aptamer-Functionalised Schottky-Field Effect Transistor for the Detection of Proteins.Biosensors · 2022Article
- Plasmonic Nanohole Arrays on Top of Porous Silicon Sensors: A Win-Win Situation.ACS applied materials & interfaces · 2021Article
- PNA-Based Graphene Oxide/Porous Silicon Hybrid Biosensor: Towards a Label-Free Optical Assay for Brugada Syndrome.Nanomaterials (Basel, Switzerland) · 2020Article
- A lectin-coupled porous silicon-based biosensor: label-free optical detection of bacteria in a real-time mode.Scientific reports · 2020Article
- Porous Silicon Optical Biosensors: Still a Promise or a Failure?Sensors (Basel, Switzerland) · 2019Review
- Silicon Nanotubes as Potential Therapeutic Platforms.Pharmaceutics · 2019Review
- Porous Silicon-Based Aptasensors: The Next Generation of Label-Free Devices for Health Monitoring.Molecules (Basel, Switzerland) · 2019Review
- Functionalized Polymeric Materials with Bio-Derived Antimicrobial Peptides for "Active" Packaging.International journal of molecular sciences · 2019Article
- Extending the Shelf-Life of Meat and Dairy Products via PET-Modified Packaging Activated With the Antimicrobial Peptide MTP1.Frontiers in microbiology · 2019Article
- Diatoms Green Nanotechnology for Biosilica-Based Drug Delivery Systems.Pharmaceutics · 2018Review
- A new strategy for label-free detection of lymphoma cancer cells.Biomedical optics express · 2015Article
- Synthesis of mixed-sequence oligonucleotides on mesoporous silicon: chemical strategies and material stability.Nanoscale research letters · 2014Article
- Nanoparticle-based strategy for personalized B-cell lymphoma therapy.International journal of nanomedicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct solid phase synthesis of peptides and oligonucleotides (ONs) requires high chemical stability of the support material. In this work, we have investigated the passivation ability of porous oxidized silicon multilayered structures by two aminosilane compounds, 3-aminopropyltriethoxysilane and 3-aminopropyldimethylethoxysilane (APDMES), for optical label-free ON biosensor fabrication. We have also studied by spectroscopic reflectometry the hybridization between a 13 bases ON, directly grown on the aminosilane modified porous oxidized silicon by in situ synthesis, and its complementary sequence. Even if the results show that both devices are stable to the chemicals (carbonate/methanol) used, the porous silica structure passivated by APDMES reveals higher functionalization degree due to less steric hindrance of pores.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.